63861-26-7

Basic information

• Product Name: Cyclopentanecarboxylic acid, 2,2-diMethyl-
• Synonyms: Cyclopentanecarboxylic acid, 2,2-diMethyl-;2,2-Dimethylcyclopentanecarboxylic acid;2,2-dimethylcyclopentane-1-carboxylic acid
• CAS NO: 63861-26-7
• Molecular Formula: C8H14O2
• Molecular Weight: 142.19556
• Mol File: 63861-26-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 227.8 °C at 760 mmHg
• Flash Point: 107.3 °C
• Appearance: /
• Density: 1.02 g/cm³
• PKA: 4.82±0.40(Predicted)
• CAS DataBase Reference: Cyclopentanecarboxylic acid, 2,2-diMethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclopentanecarboxylic acid, 2,2-diMethyl-(63861-26-7)
• EPA Substance Registry System: Cyclopentanecarboxylic acid, 2,2-diMethyl-(63861-26-7)

Safety Data

• Hazardous Substances Data: 63861-26-7(Hazardous Substances Data)

Usage

General Description

Cyclopentanecarboxylic acid, 2,2-dimethyl- is a chemical compound with the molecular formula C9H16O2. It is a carboxylic acid and belongs to the cyclopentanecarboxylic acid family. The compound is characterized by a cyclopentane ring with a carboxylic acid group and two methyl groups attached to the carbon atom. It is used in organic synthesis and as a building block for the synthesis of various compounds. This chemical has various industrial applications, including in the production of pharmaceuticals, agrochemicals, and other fine chemicals. Additionally, it has been studied for its potential biological and pharmacological properties.

Upstream product

• 583-60-8 2-Methylcyclohexanone 
• 1193-47-1 2,2-dimethyl-cyclohexanone 
• 92383-42-1 6-amino-2,2-dimethyl-cyclohexanone 
• 92383-43-2 6-amino-2,2-dimethyl-cyclohexanone; hydrochloride 

Relevant articles and documents

5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY

The invention relates to heteroaryl compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.

Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable IKs blockers

Multiple delayed rectifier potassium currents, including IKs, are responsible for the repolarization and termination of the cardiac action potential, and blockers of these currents may be useful as antiarrhythmic agents. Modification of compound 5 produced 19(S) that is the most potent IKs blocker reported to date with > 5000-fold selectivity over other cardiac ion channels. Further modification produced 24A with 23% oral bioavailability.